“Homology Medicines will lay off scores of its employees and stop research in a reset meant to position the company for a sale, merger or other business combination.”
1 Discontinued Drug: HMI-203 for treatment of Mucopolysaccharidosis type II (MPS II)
1 Discontinued Research Program
